Cara Therapeutics
Get Full AccessDescription
- Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat pain, inflammation and pruritus. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics.Cara's most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and uremic pruritus. This compound possesses analgesic, anti-inflammatory and antipruritic activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.
-
Headquarters:4 Stamford Plaza , Town Of Stamford, Connecticut, United States
More -
Phone Number: +1 203-567-1500
-
Website: https://www.caratherapeutics.com
-
Employees:81
-
Revenue:$100 - 250M
-
Legal Name:Cara Therapeutics
-
Cara Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 541715 |
Show More
Frequently Asked Questions regarding Cara Therapeutics
-
Where are Cara Therapeutics's Headquarters?
Cara Therapeutics's Headquarters are in 4 Stamford Plaza ,Town Of Stamford,Connecticut,United States
-
What is Cara Therapeutics's phone number?
Cara Therapeutics's phone number is +1 203-567-1500
-
What is Cara Therapeutics's official website?
Cara Therapeutics's official website is https://www.caratherapeutics.com
-
What is Cara Therapeutics's Revenue?
Cara Therapeutics's revenue is $100 - 250M
-
What is Cara Therapeutics's NAICS code?
Cara Therapeutics's NAICS code is 541715
-
How many employees are working in Cara Therapeutics
Cara Therapeutics has 81 employees
-
What is Cara Therapeutics's Industry?
Cara Therapeutics is in the industry of Biotechnology
-
Who is Cara Therapeutics's CEO?
Cara Therapeutics's CEO is Chris Posner

